- Email: [email protected]
5541065 Method for HLA DP typing
400
PATENT ABSTRACTS
stained with an alkaline phosphatase technique including a monoclonal antibody specific to a protein in at least one of the cell's cytoplasm or on a cell membrane, thereby marking any cells including the protein as to type. A second staining of the DNA in the nucleus is accomplished by a Feulgen technique that destroys the cell cytoplasm. After the staining and marking, the cells may then be gated using the image analysis means on the visual parameter such as colored DNA or colored antigen into a subpopulation that is to be measured. The selected cells may then be examined by digital image processing and measured for a parameter such as a true actual measurement of DNA in picograms. A quantitation of the measured parameter may be generated and provided.
5541066 ASSAYS FOR CARTILAGE SYNTHESIS IN OSTEOARTHRITIS BASED ON DETECTION OF TYPE IIA MRNA Sandell Linda J Seattle, UNITED STATES Assays for determining cartilage synthesis associated with osteoarthritis are presented. The assays are based on detection of collagen type IIA procollagen or propeptide, or collagen type IIA mRNA in a tissue or fluid sample from a non-neonatal individual being tested. Since type II A procollagen is not found in normal non-neonatal individuals, type IIA procollagen and the mRNA which encodes it are unique markers for osteoarthdtis which exhibits neonatal like cartilage synthesis as part of the disease syndrome.
5541065 M E T H O D FOR HLA DP TYPING Erlich Henry A; Horn Glenn; Bugawan Teodorica; Begovich Ann B Oakland, CA, UNITED STATES Assigned to Hoffmann-La Roche Inc A process for determining the genotype of an individual with respect to the alleles at the HLA DP locus involves obtaining a sample of nucleic acid from the individual, and hybridizing the nucleic acids with a panel of probes specific for variant segments of DPalpha and DPbeta genes. Because the variation between DPbeta alleles is highly dispersed throughout the second exon of the DPbeta gene, the discovery of many different DPbeta alleles makes the process far more discriminating and informative than cellular, RFLP, or serological methods. The process can also be carried out on amplified nucleic acid produced by the polymerase chain reaction using primers specific for the second exon of the DPalpha and DPbeta genes. HLA DP DNA typing methods are useful in the prevention of graft rejection and host versus graft disease, in determining susceptibdity to autoimmune diseases, in providing evidence concerning the derivation from an individual of forensic samples, and in paternity testing.
5541067 M E T H O D AND SYSTEM FOR GENOTYPING Perlin Mark Pittsburgh, PA, UNITED STATES The present invention pertains to a process which can be fully automated for accurately determining the alleles of STR genetic markers. More specifically, the present invention is related to performing PCR amplification on locations of DNA, labelling the PCR products, converting the labels into a signal, removing a reproducible PCR stutter pattern from the signal by means of a computational device, and then determining the genotype of the location of the DNA. An amplification can include multiple locations from the DNA of one or more individuals. The invention also pertains to genetics applications and systems which can effectively use this genotyping information.
PATENT ABSTRACTS
stained with an alkaline phosphatase technique including a monoclonal antibody specific to a protein in at least one of the cell's cytoplasm or on a cell membrane, thereby marking any cells including the protein as to type. A second staining of the DNA in the nucleus is accomplished by a Feulgen technique that destroys the cell cytoplasm. After the staining and marking, the cells may then be gated using the image analysis means on the visual parameter such as colored DNA or colored antigen into a subpopulation that is to be measured. The selected cells may then be examined by digital image processing and measured for a parameter such as a true actual measurement of DNA in picograms. A quantitation of the measured parameter may be generated and provided.
5541066 ASSAYS FOR CARTILAGE SYNTHESIS IN OSTEOARTHRITIS BASED ON DETECTION OF TYPE IIA MRNA Sandell Linda J Seattle, UNITED STATES Assays for determining cartilage synthesis associated with osteoarthritis are presented. The assays are based on detection of collagen type IIA procollagen or propeptide, or collagen type IIA mRNA in a tissue or fluid sample from a non-neonatal individual being tested. Since type II A procollagen is not found in normal non-neonatal individuals, type IIA procollagen and the mRNA which encodes it are unique markers for osteoarthdtis which exhibits neonatal like cartilage synthesis as part of the disease syndrome.
5541065 M E T H O D FOR HLA DP TYPING Erlich Henry A; Horn Glenn; Bugawan Teodorica; Begovich Ann B Oakland, CA, UNITED STATES Assigned to Hoffmann-La Roche Inc A process for determining the genotype of an individual with respect to the alleles at the HLA DP locus involves obtaining a sample of nucleic acid from the individual, and hybridizing the nucleic acids with a panel of probes specific for variant segments of DPalpha and DPbeta genes. Because the variation between DPbeta alleles is highly dispersed throughout the second exon of the DPbeta gene, the discovery of many different DPbeta alleles makes the process far more discriminating and informative than cellular, RFLP, or serological methods. The process can also be carried out on amplified nucleic acid produced by the polymerase chain reaction using primers specific for the second exon of the DPalpha and DPbeta genes. HLA DP DNA typing methods are useful in the prevention of graft rejection and host versus graft disease, in determining susceptibdity to autoimmune diseases, in providing evidence concerning the derivation from an individual of forensic samples, and in paternity testing.
5541067 M E T H O D AND SYSTEM FOR GENOTYPING Perlin Mark Pittsburgh, PA, UNITED STATES The present invention pertains to a process which can be fully automated for accurately determining the alleles of STR genetic markers. More specifically, the present invention is related to performing PCR amplification on locations of DNA, labelling the PCR products, converting the labels into a signal, removing a reproducible PCR stutter pattern from the signal by means of a computational device, and then determining the genotype of the location of the DNA. An amplification can include multiple locations from the DNA of one or more individuals. The invention also pertains to genetics applications and systems which can effectively use this genotyping information.